D. Chesov (Chisinau, Republic of Moldova), S. Rosales-Klintz (Solna, Sweden), R. Ferreira Duarte Bessa Melo (Porto, Portugal)
Immigrants’ access to health care: problems identified in a high-risk tuberculosis population R. Linhas (Porto, Portugal)
| |
Tuberculosis in Moldovan labour migrants L. Evelina (Chisinau, Republic of Moldova)
| |
Active tuberculosis cases in migrants in Newham: should we extend screening criteria for latent tuberculosis infection G. Ransley (London, United Kingdom)
| |
Impact of systematic screening on the burden of tuberculosis in Azerbaijan prisons E. Gurbanova (BAKU, Azerbaijan)
| |
Treatment of DR-TB in penitential system of Georgia with new TB-medications. N. Kiria (Tbilisi, Georgia)
| |
Incidence of latent tuberculosis infection(LTBI) among high risk healthcare workers at a tertiary referral hospital in South Korea. H. Kim (Seoul, Republic of Korea)
| |
Opportunistic screening for Tuberculosis in homeless patients A. Banerjee (Eastleigh, United Kingdom)
| |
Efficacy of isoniazid preventive therapy for latent tuberculosis infection in patients with immune-mediated inflammatory disorders-a retrospective cohort study in Taiwan W. Su (Taipei, Taiwan)
| |
Tuberculosis in patients on TNFa inhibitor treatment in Latvia. A. Nodieva (Stopinu nov., Latvia)
| |
Impact of enhanced case finding on case notification rate in pulmonary tuberculosis A. Prakash (GURGAON (HARYANA), India)
| |
Contact tracing in pulmonary versus non-pulmonary tuberculosis- the impact of the 2016 NICE guidelines? C. Craig (Manchester, United Kingdom)
| |
Review of Tuberculosis outbreak in a Boarding School in Bolton, United Kingdom R. Ahmed (Bolton, United Kingdom)
| |
Are TB services in England adhering to new NICE guidelines on screening for latent TB? C. Craig (Manchester, United Kingdom)
| |
Diaskintest at patients after successful treatment of lung tuberculosis G. Balasaniantc (Leningrad Oblast, Russian Federation)
| |
Combinatorial ELISPOT and T-cell immunoprofiling with CD25+/CD134+ co-expression in latent TB infection P. Escalante (Rochester, United States of America)
| |
Modulation of QuantiFERON-TB-Gold Plus response in patients with active tuberculosis and latent infection during treatment E. Petruccioli (Roma, Rm, Italy)
| |